10-May-2011
Asia Pacific
Market Research
P43E-01-00-00-00
HC02321-AP-MR_08313
This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.
Brief Summary of Indian Biosimilar Market
- Executive Summary of the Biosimilar market
- Future Impact
Overview of Global Biosimilar Market
- Introduction to Biosimilars
- Global Population Demographics
- Key Biodrugs
- Types of Products Manufactured by Major Participants
- Market Size of Biosimilars: Global
- Market Size: Biologic Patents Expiring in 2011-2016
- Market Size: Biologics Patents Expiring 2016-2019
- Market Size : Worldwide Sales of Key Biodrugs
- Market Opportunities
- Market Size of Biosimilars: Revenue Forecasts
- Major Participants - Global
- Major Participants - Trends
Overview if Indian Biosimilar Market
- Overview of Indian Biosimilar Market
- Timeline of Indian Market
- Indian Market Portfolio
- Domestic Market Potential
- Market Drivers Ranked in Order of Impact
- General Factors favoring the market
- Market Restraints Ranked in Order of Impact
- Hurdles faced by Indian Participants
- Domestic Market Potential - Observed Trends in Market
- Export Potential - Overview
- Export Potential - Expansion Strategy of Indian Participants
- Overview of Highly Regulated Markets: Europe
- Overview of Highly Regulated Markets: The United States
- Overview of Semi-regulated Markets: China
- Cost Advantage of India
- Biosimilar Market in India: Revenue Forecasts
Overview of Regulatory Scenario
- Indian Regulations for Biosimilars
- International Regulatory Authorities European Medicines Agency (EMA)
- International Regulatory Authorities US-FDA
Overview of Major Participants in the Indian Market
- Biocon
- Dr. Reddy’s
- Ranbaxy
- Wockhardt
- Intas Biopharmaceuticals
- Shantha Biotech
Overview of Historical trends and Future Impact
- 2001-2010: A Historical View of the Biosimilar Market
- 2010-2015: Frost & Sullivan View on the Biosimilars Market
Overview of Chinese Biosimilar Market
- Overview of Biosimilar Market in China
- China – Major Participants
Frost and Sullivan: Overview
- Who is Frost and Sullivan
- What makes us unique
- T.E.A.M. Methodology
- Global Perspective
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
26 Aug 2026 | Global | Technology Research
Growth Opportunities and Advancements in Acute and Chronic Wound Care
A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...
26 Aug 2026 | Global | Frost Radar
Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026
Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | P43E-01-00-00-00 |
| Is Prebook | No |
Strategic Analysis of Indian Biosimilar Market
$4,950.00
Special Price $3,712.50 save 25 %